| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 07/13/2006 | US20060154248 Manufacturing method and readout system for biopolymer arrays |
| 07/13/2006 | US20060153876 Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease |
| 07/13/2006 | US20060153813 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 07/12/2006 | EP1678315A2 Engineered zinc finger proteins for regulation of gene expression |
| 07/12/2006 | EP1678292A2 Improved mva vaccines |
| 07/12/2006 | EP1678291A2 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 07/12/2006 | EP1678121A2 Tao kinase modulators and methods of use |
| 07/12/2006 | EP1677778A2 Method of treating airway diseases with beta-adrenergic inverse agonists |
| 07/12/2006 | EP1677606A2 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels |
| 07/12/2006 | CN1800397A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 07/11/2006 | CA2277983C Tyrosine phosphorylated cleavage furrow-associated proteins (pstpips) |
| 07/06/2006 | WO2005049798A3 Chromosome 5 genetic variants related to dyslexia |
| 07/06/2006 | WO2005017111A3 Methods and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same |
| 07/06/2006 | WO2005017104A3 Cancer-linked gene as target for chemotherapy |
| 07/06/2006 | WO2005003326A3 Artificial receptors including reversibly immobilized building blocks and methods |
| 07/06/2006 | WO2005003317A3 Engineered blood vessels |
| 07/06/2006 | WO2005003313A8 Methods and compositions for enhanced protein expression and purification |
| 07/06/2006 | WO2004101761A3 METHODS FOR THE IDENTIFICATION OF INHIBITORS OF CAX1-LIKE Ca+2/H+ANTIPORTER ACTIVITY IN PLANTS |
| 07/06/2006 | WO2004043232A3 Methods for identifying risk of melanoma and treatments thereof |
| 07/06/2006 | WO2004035730A3 Crystals and structures of atp phosphoribosyltransferase |
| 07/06/2006 | US20060150273 Grass endophytes |
| 07/06/2006 | US20060149047 N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor |
| 07/06/2006 | US20060149042 the starting solution to ultrafiltration to concentrate the macromolecule, adjusting the conductivity of the first retentate solution followed by ultrafiltration |
| 07/06/2006 | US20060147975 Method for assaying protein-protein interaction |
| 07/06/2006 | US20060147946 Novel calcium channel variants and methods of use thereof |
| 07/06/2006 | US20060147377 tumor cell line, reponsive to histone deacetylase inhibitors, transfected with vector containing reporter gene such as fluorescent protein, linked to promotor that also controls expression of protein associated with tumor regression, stabilization of tumor growth or inhibition of metastatic growth |
| 07/05/2006 | EP1676916A1 Hamster EF-1Alpha transcriptional regulatory DNA |
| 07/05/2006 | EP1676586A1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 07/05/2006 | EP1676133A2 Assays with primary cells |
| 07/05/2006 | EP1676122A2 Methods for enhancing the analysis of particle detection |
| 07/05/2006 | EP1675943A2 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof |
| 07/05/2006 | EP1675620A2 Polymer derivatives |
| 07/05/2006 | EP1675607A2 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 07/05/2006 | EP1620728A4 Chromatographic assay system |
| 07/05/2006 | CN1798836A Methods for preventing gluconoylation of proteins |
| 07/04/2006 | US7070965 Small molecule anticancer compounds and related production process |
| 06/29/2006 | WO2006068492A1 A novel polynucleotide involved in heritable parkinson's disease |
| 06/29/2006 | WO2005019435A3 Anti-cancer vaccines |
| 06/29/2006 | WO2005001050A3 Transcription factors |
| 06/29/2006 | WO2004085609A3 Nanopores, methods for using same, methods for making same and methods for characterizing biomolecules using same |
| 06/29/2006 | WO2004015080A3 Nucleic acid detection methods using universal priming |
| 06/29/2006 | WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 06/29/2006 | US20060142548 Methods of identifying and designing cell surface receptor inhibitors |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141475 Polynucleotide sequence detection assays and analysis |
| 06/29/2006 | US20060141457 Nucleotide sequence encoding an acyltransferase polypeptide comprising membrane-spanning region; immobilization, freeze drying; contacting vegetable oil with polypeptide wherein fatty acids are transferred from phospholipid to an acceptor molecule; ester interchange; lecithin is converted to lysolecithin |
| 06/29/2006 | US20060140958 Tumor antigen (TAG); labeled nucleotide sequence; gives rise to antigenic peptides which bind to major histocompatibility complex and recognized by cytotoxic lymphocytes; diagnosis and treatment of cancer |
| 06/29/2006 | US20060140908 Methods for inducing an immune response via oral administration of an adenovirus |
| 06/29/2006 | CA2606672A1 A novel polynucleotide involved in heritable parkinson's disease |
| 06/28/2006 | EP1673478A2 Competition assay for identifying modulators of quadruplex nucleic acids |
| 06/28/2006 | EP1673441A2 Long-wavelength fps |
| 06/28/2006 | EP1673439A2 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 06/28/2006 | EP1673438A2 Transgenic rodents selectively expressing human b1 bradykinin receptor protein |
| 06/28/2006 | EP1673437A2 Compositions and methods for synthesizing, purifying and detecting biomolecules |
| 06/28/2006 | EP1673436A2 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 06/28/2006 | EP1673394A2 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 06/28/2006 | CN1795380A Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 06/28/2006 | CN1795274A Selected rna motifs to include cell death and/or apoptosis |
| 06/28/2006 | CN1795205A Spex compositions and methods of use |
| 06/28/2006 | CN1795199A Method of alpha-selective glycosylation |
| 06/27/2006 | US7067298 Compositions and methods of using a synthetic Dnase I |
| 06/27/2006 | CA2195935C Streptococcus equi vaccine |
| 06/22/2006 | WO2005054428A3 Method for inhibiting cancer cells |
| 06/22/2006 | WO2005047466A3 Apparatus and method for tissue engineering |
| 06/22/2006 | WO2005042703A3 Placental stem cells and uses thereof |
| 06/22/2006 | WO2005030925A3 Microfluidic rotary flow reactor matrix |
| 06/22/2006 | WO2005021709A9 Cln101 antibodies |
| 06/22/2006 | WO2005001051A3 Compositions and methods for regulating polysaccharides of a plant cell |
| 06/22/2006 | WO2004101738A3 Domain-exchanged binding molecules, methods of use and methods of production |
| 06/22/2006 | US20060137043 metabolic activity is altered by transformation with a Stress-Related Protein (SRP) coding nucleic acid |
| 06/22/2006 | US20060135594 Dihydropyrrole derivatives; 3-{(2S)-4-(2,5-difluorophenyl)-1-[(dimethylamino)carbonyl]-2,5-dihydro- 1H-pyrrol-2-yl}phenyl dihydrogen phosphate; anticarcinogenic agents; cellular proliferative diseases; specificity; side effect reduction |
| 06/22/2006 | US20060135410 Targeted delivery to legumain-expressing cells |
| 06/22/2006 | US20060134740 Engineered proteases for affinity purification and processing of fusion proteins |
| 06/22/2006 | US20060134687 Microfluidic differential extraction cartridge |
| 06/22/2006 | US20060134668 Methods for treating patients and identifying therapeutics |
| 06/22/2006 | US20060134266 Enzyme |
| 06/21/2006 | EP1670952A2 Methods for identifying a biosynthetic pathway gene product |
| 06/21/2006 | EP1670948A2 GENE MODULATION BY RB2/p130 EXPRESSION |
| 06/21/2006 | EP1670932A2 Libraries of recombinant chimeric proteins |
| 06/21/2006 | EP1670902A2 METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG |
| 06/21/2006 | EP1670901A2 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
| 06/21/2006 | EP1670900A2 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 06/21/2006 | EP1670899A2 Vaccines for cancer, autoimmune disease and infections |
| 06/21/2006 | EP1670898A2 Microfluidic rotary flow reactor matrix |
| 06/21/2006 | EP1670897A2 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 06/21/2006 | EP1670895A2 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof |
| 06/21/2006 | EP1670893A2 Immunogenic hiv compositions and related methods |
| 06/21/2006 | EP1670873A2 Organic cooling medium and its uses |
| 06/21/2006 | EP1670811A2 Shc proteins as therapeutic targets in proliferative diseases |
| 06/21/2006 | EP1670513A2 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy |
| 06/21/2006 | EP1670493A2 In vitro development of tissues and organs |
| 06/21/2006 | EP1670456A2 Compounds, compositions and methods |
| 06/21/2006 | EP1629095A4 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 06/20/2006 | US7064624 Power conditioners and pseudo isolation for a two-wire processing network |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/15/2006 | WO2005049796A8 Chromosome 5 genetic variants related to dyslexia |
| 06/15/2006 | WO2005028627A3 Performing sequence analysis as a relational join |
| 06/15/2006 | WO2005005599A3 Modulation of c-reactive protein expression |
| 06/15/2006 | WO2004094596A8 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2006 | WO2004090113A3 L53, a lung cancer associated antigen and uses thereof |